TAP funded Tier study for relapsed and refractory CNS lymphoma patients
How does a patient’s personal situation affect CLL treatment choice?
The question of drug combinations for consolidation and maintenance for multiple myeloma
How new drugs are changing the landscape for transplant in lymphoma
An overview of iwCLL 2017 meeting in New York by Prof. Michael Hallek